1784 logo

BIONET Corp. Stock Price

TPEX:1784 Community·NT$2.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

1784 Share Price Performance

NT$57.10
-16.50 (-22.42%)
NT$57.10
-16.50 (-22.42%)
Price NT$57.10

1784 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet second-rate dividend payer.

2 Risks
0 Rewards

BIONET Corp. Key Details

NT$1.3b

Revenue

NT$564.7m

Cost of Revenue

NT$695.8m

Gross Profit

NT$647.0m

Other Expenses

NT$48.8m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.97
55.20%
3.87%
4.1%
View Full Analysis

About 1784

Founded
1989
Employees
n/a
CEO
Qing Yuan Kang
WebsiteView website
www.bionetcorp.com

BIONET Corp. engages in cell therapy, regenerative medicine, medical big data, gene testing, and sales of biological and scientific information hardware and software business in Taiwan and internationally. The company offers stem cell banking services, such as stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC and immune cells, as well as skin care products. It also provides storage and application of hematopoietic stem cells, analytical testing, clinical and preclinical research, commercialized cell-derived products, and Exosome, a cell-free therapy. The company was founded in 1989 and is based in Taipei City, Taiwan.

Recent 1784 News & Updates

Recent updates

No updates